|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 1201 Maryland Avenue SW |
Address2 | Suite 900 |
| City | Washington |
State | DC |
Zip Code | 20024 |
Country | USA |
3. Principal place of business (if different than line 2)
| City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 6245-12
|
||||||||
|
6. House ID# 325050000
|
||||||||
| TYPE OF REPORT | 8. Year | 2013 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Brent DelMonte, Vice President for Federal Government Relations |
Date | 01/29/2014 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code AGR
16. Specific lobbying issues
EPA Regulations on Agricultural Biotechnology
Herbicide Label Changes
Efficient Science-Based Review of Biotech Products
Livestock Cloning/Product Labeling
Discussions with EU on Animal Cloning
Genetically Engineered (GE) Animals
Labeling
S. 1244/H.R. 2410: Agriculture, Rural Development, FDA, and Related Appropriations Act for FY 2014
Amendment on GE Salmon Labeling (Senate)
H.J. Res. 59: The Bipartisan Budget Act of 2013
Amendment on GE Salmon Labeling
Labeling of Food Derived From Biotechnology
S.1244/H.R. 2410: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014
U.S. Government Policy
TransPacific Partnership
Sanitary and Phytosanitary Issues
Adventitious Presence
International Low Level Presence Policies
Foreign Agricultural Biotechnology Laws and Regulations
China Biotechnology Regulations
Asynchrony of International Approvals
Biomass Programs
Reauthorization of Biomass Crop Assistance Program
Reauthorization of Biomass R&D Program
S.954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
Transatlantic Trade and Investment Partnership
Ag-Biotech Issues
USDA/APHIS Agricultural Biotechnology Regulations
Efficient Science-Based Review of Biotech Products
Coordination of Federal Biotechnology Research
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA), U.S. Trade Representative (USTR),
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Cathleen |
Enright |
|
|
|
David |
Edwards |
|
|
|
Tracey |
LaTurner |
|
|
|
Dana |
O'Brien |
|
|
|
Matthew |
Carr |
|
|
|
Brent |
Del Monte |
|
|
|
Erick |
Lutt |
|
|
|
Matthew |
O'Mara |
|
|
|
Anna |
Weinstein |
|
|
|
Tom |
Dilenge |
|
|
|
Matthew |
Schumaker |
|
|
|
Rina |
Singh |
|
|
|
Charles |
Fritts |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ANI
16. Specific lobbying issues
Livestock Cloning/Product Labeling
Discussions with EU on Animal Cloning
Genetically Engineered (GE) Animals
Labeling
S. 1244/H.R. 2410: Agriculture, Rural Development, FDA, and Related Appropriations Act for FY 2014
Amendment on GE Salmon Labeling (Senate)
H.J. Res. 59: The Bipartisan Budget Act of 2013
Amendment on GE Salmon Labeling
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, U.S. Trade Representative (USTR)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tracey |
LaTurner |
|
|
|
Dana |
O'Brien |
|
|
|
David |
Edwards |
|
|
|
Brent |
DelMonte |
|
|
|
Anna |
Weinstein |
|
|
|
Cathleen |
Enright |
|
|
|
. |
. |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
S. 1284: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014
H.J. Res. 59: The Bipartisan Budget Act of 2013
Funding for FDA
H.R. 2410/S. 1244: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014
H.J. Res. 59: The Bipartisan Budget Act of 2013
Funding for Centers for Disease Control and Prevention Vaccine Programs
S. 1284: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014
Funding for National Institutes of Health
S. 1284: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014
Sequestration of PDUFA Fees
Implementation of S. 365: Budget Control Act
H.J. Res. 59: The Bipartisan Budget Act of 2013
H.R. 2410/S. 1244: Agriculture, Rural Development, FDA and Related Agencies Appropriations Act FY 2014
HR 2725: Food and Drug Administration Safety over Sequestration Act of 2013
S. 1413: FDA User Fee Protection Act
Energy Basic Research Funding
DOE Office of Science
Advanced Research Projects Agency - Energy
Energy and Water Development and Related Agencies Appropriations Act for FY 2014
Funding for Renewable Chemicals/Bio-based Products
Expansion of Biorefinery Assistance Program to Renewable Chemicals and Bio-based Products
H.J. Res. 59: Bipartisan Budget Act of 2013
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S.954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
Funding for Biofuels
Department of Defense Funding of Advanced Biofuels
H.J. Res. 59: The Bipartisan Budget Act of 2013
Energy and Water Development and Related Agencies Appropriations Act for FY 2014
H.R. 2397: Department of Defense Appropriations Act for FY 2014
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S.954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
Funding for Biorefineries
Reauthorization/Funding of Biorefinery Grant and Loan Programs
H.J. Res. 59: The Bipartisan Budget Act of 2013
H.R. 1960/S. 1034: National Defense Authorization Act for FY 2014
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Natl Security Council (NSC), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tracey |
LaTurner |
|
|
|
Matthew |
Carr |
|
|
|
Anna |
Weinstein |
|
|
|
Andrew |
Emmett |
|
|
|
Catharine |
Harris |
|
|
|
Brent |
DelMonte |
|
|
|
Derrick |
White |
|
|
|
Sara |
Radcliffe |
|
|
|
Jeanne |
Haggerty |
|
|
|
Kelly |
Cappio |
|
|
|
Erick |
Lutt |
|
|
|
Phyllis |
Arthur |
|
|
|
Matthew |
Schumaker |
|
|
|
Dana |
O'Brien |
|
|
|
Catharine |
Harris |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
Genetic Resource Patent Disclosure Requirement
World Intellectual Property Organization
Patent Reform
House Judiciary Committee Discussion Draft (Rep. Bob Goodlatte)
H.R. 3309: The Innovation Act of 2013
H.R. 845: The SHIELD Act of 2013
S. 1013: Patent Abuse Reduction Act of 2013
S. 1720: Patent Transparency and Improvements Act of 2013
S. 866: Patent Quality Improvement Act of 2013
Implementation of H.R. 1249: The America Invents Act of 2011
Intellectual Property International Enforcement
TransPacific Partnership
Data and Intellectual Property Protections for Pharmaceuticals
Transatlantic Trade and Investment Partnership
Intellectual Property Issues
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, U.S. Trade Representative (USTR),
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Catharine |
Harris |
|
|
|
Hans |
Sauer |
|
|
|
Jeanne |
Haggerty |
|
|
|
Brent |
Del Monte |
|
|
|
Tom |
DiLenge |
|
|
|
Joseph |
Damond |
|
|
|
Charles |
Fritts |
|
|
|
Anna |
Weinstein |
|
|
|
Derrick |
White |
|
|
|
Matthew |
Schumaker |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CSP
16. Specific lobbying issues
Livestock Cloning/Product Labeling
Discussions with EU on Animal Cloning
Genetically Engineered (GE) Animals
Labeling
S. 1244/H.R. 2410: Agriculture, Rural Development, FDA, and Related Appropriations Act for FY 2014
Amendment on GE Salmon Labeling (Senate)
H.J. Res. 59: The Bipartisan Budget Act of 2013
Amendment on GE Salmon Labeling
Labeling of Food Derived From Biotechnology
S.1244/H.R. 2410: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014
U.S. Government Policy
Funding for FDA
H.R. 2410/S. 1244: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014
H.J. Res. 59: The Bipartisan Budget Act of 2013
Drug Evaluation and Review
Special Medical Use/Limited Population Drug
H.R. 3742: Antibiotic Development to Advance Patient Treatment Act of 2013
Implementation of the FDA Safety and Innovation Act
Biosimilars
Naming
Colombia Biologics Regulations
Interchangeability and Pharmacy Substitution
Implementation of Affordable Care Act
Drug Manufacturing, Quality & Distribution
Supply Chain Integrity
Pharmacy Compounding & Oversight
Drug Shortages
H.R. 3204: The Drug Quality and Security Act
USDA/APHIS Agricultural Biotechnology Regulations
Efficient Science-Based Review of Biotech Products
17. House(s) of Congress and Federal agencies Check if None
Agriculture - Dept of (USDA), Federal Trade Commission (FTC), Health & Human Services - Dept of (HHS), Natl Security Council (NSC), U.S. Trade Representative (USTR), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Cathleen |
Enright |
|
|
|
David |
Edwards |
|
|
|
Andrew |
Emmett |
|
|
|
Anna |
Weinstein |
|
|
|
Sara |
Radcliffe |
|
|
|
Jeanne |
Haggerty |
|
|
|
Derrick |
White |
|
|
|
Dana |
O'Brien |
|
|
|
Matthew |
Schumaker |
|
|
|
Tom |
DiLenge |
|
|
|
Brent |
DelMonte |
|
|
|
Cartier |
Esham |
|
|
|
Tracey |
LaTurner |
|
|
|
Catharine |
Harris |
|
|
|
. |
. |
|
|
|
. |
. |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENG
16. Specific lobbying issues
Biofuels
Production Tax Credit Extension
Renewable Fuel Standard
Accelerated Depreciation Extension
Biofuels Cont...
Department of Defense Application of Advanced Biofuels
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
H.R. 1960/S. 1034: National Defense Authorization Act
H.R. 3758: Second Generation Biofuel Extension Act of 2013
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
Biorefineries
Reauthorization of Biorefinery Assistance Program
H.R. 1960/S. 1034: National Defense Authorization Act
HR 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
Renewable Chemicals/Bio-based Products
Investment Tax Credit for Renewable Chemicals and Bio-based Products
New Production Tax Credit for Renewable Chemicals
Reauthorization of USDA Bio-Preferred Program
Expansion of Master Limited Partnerships to Renewable Chemicals
H.R. 1696/S. 795: Master Limited Partnerships Parity Act
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
H.R. 2421: Renewable Chemicals Parity Act
S. 1267/H.R. 3084: Renewable Chemical Production Tax Credit Act
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
Biomass Programs
Reauthorization of Biomass R&D Program
Reauthorization of Biomass Crop Assistance Program
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S.954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
Energy Basic Research Funding
DOE Office of Science
Advanced Research Projects Agency - Energy
Energy and Water Development and Related Agencies Appropriations Act for FY 2014
Funding for Renewable Chemicals/Bio-based Products
Expansion of Biorefinery Assistance Program to Renewable Chemicals and Bio-based Products
H.J. Res. 59: Bipartisan Budget Act of 2013
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S.954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
Funding for Biofuels
Department of Defense Funding of Advanced Biofuels
H.R. Res. 59: Bipartisan Budget Act of 2013
Energy and Water Development and Related Agencies Appropriations Act for FY 2014
H.R. 2397: Department of Defense Appropriations Act for FY 2014
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S.954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
Funding for Biorefineries
Reauthorization/Funding of Biorefinery Grant and Loan Programs
H.J. Res. 59: Bipartisan Budget Act of 2013
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
Funding for Biorefineries Cont...
H.R. 1960/S. 1034: National Defense Authorization Act for FY 2014
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
Coordination of Federal Biotechnology Research
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Environmental Protection Agency (EPA), U.S. Trade Representative (USTR)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Carr |
|
|
|
Dana |
O'Brien |
|
|
|
Tracey |
LaTurner |
|
|
|
Charles |
Fritts |
|
|
|
Rina |
Singh |
|
|
|
Brent |
Del Monte |
|
|
|
Erick |
Lutt |
|
|
|
Cathleen |
Enright |
|
|
|
Matthew |
Schumaker |
|
|
|
Tom |
DiLenge |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOO
16. Specific lobbying issues
Livestock Cloning/Product Labeling
Discussions with EU on Animal Cloning
Genetically Engineered (GE) Animals
Labeling
S. 1244/H.R. 2410: Agriculture, Rural Development, FDA, and Related Appropriations Act for 2014
Amendment on GE Salmon Labeling (Senate)
H.J. Res. 59: The Bipartisan Budget Act of 2013
Amendment on GE Salmon Labeling
Labeling of Food Derived From Biotechnology
S.1244/H.R. 2410: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014
U.S. Government Policy
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, U.S. Trade Representative (USTR)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Cathleen |
Enright |
|
|
|
David |
Edwards |
|
|
|
Dana |
O'Brien |
|
|
|
Tracey |
LaTurner |
|
|
|
Brent |
Del Monte |
|
|
|
Anna |
Weinstein |
|
|
|
Tom |
DiLenge |
|
|
|
Jeanne |
Haggerty |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FUE
16. Specific lobbying issues
Biofuels
Production Tax Credit Extension
Renewable Fuel Standard
Accelerated Depreciation Extension
Biofuels Cont...
Department of Defense Application of Advanced Biofuels
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
H.R. 1960/S. 1034: National Defense Authorization Act
H.R. 3758: Second Generation Biofuel Extension Act of 2013
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
Biorefineries
Reauthorization of Biorefinery Assistance Program
H.R. 1960/S. 1034: National Defense Authorization Act
HR 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
Renewable Chemicals/Bio-based Products
Investment Tax Credit for Renewable Chemicals and Bio-based Products
New Production Tax Credit for Renewable Chemicals
Reauthorization of USDA Bio-Preferred Program
Expansion of Master Limited Partnerships to Renewable Chemicals
H.R. 1696/S. 795: Master Limited Partnerships Parity Act
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
H.R. 2421: Renewable Chemicals Parity Act
S. 1267/H.R. 3084: Renewable Chemical Production Tax Credit Act
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
Biomass Programs
Reauthorization of Biomass R&D Program
Reauthorization of Biomass Crop Assistance Program
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S.954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
Energy Basic Research Funding
DOE Office of Science
Advanced Research Projects Agency - Energy
Energy and Water Development and Related Agencies Appropriations Act for FY 2014
Funding for Renewable Chemicals/Bio-based Products
Expansion of Biorefinery Assistance Program to Renewable Chemicals and Bio-based Products
H.J. Res. 59: Bipartisan Budget Act of 2013
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S.954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
Funding for Biofuels
Department of Defense Funding of Advanced Biofuels
H.R. Res. 59: Bipartisan Budget Act of 2013
Energy and Water Development and Related Agencies Appropriations Act for FY 2014
H.R. 2397: Department of Defense Appropriations Act for FY 2014
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S.954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
Funding for Biorefineries
Reauthorization/Funding of Biorefinery Grant and Loan Programs
H.J. Res. 59: Bipartisan Budget Act of 2013
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
Funding for Biorefineries Cont...
H.R. 1960/S. 1034: National Defense Authorization Act for FY 2014
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
Coordination of Federal Biotechnology Research
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Environmental Protection Agency (EPA), U.S. Trade Representative (USTR)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Carr |
|
|
|
Dana |
O'Brien |
|
|
|
Tracey |
LaTurner |
|
|
|
Charles |
Fritts |
|
|
|
Rina |
Singh |
|
|
|
Brent |
DelMonte |
|
|
|
Erick |
Lutt |
|
|
|
Cathleen |
Enright |
|
|
|
Matthew |
Schumaker |
|
|
|
Tom |
DiLenge |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Funding for National Institutes of Health
S. 1284: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014
Biosimilars
Colombia Biologics Regulations
Interchangeability and Pharmacy Substitution
Naming
Implementation of Affordable Care Act
Funding for Centers for Disease Control and Prevention Vaccine Programs
S. 1284: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014
Vaccine Access/Financing
Vaccine Injury Compensation Program
Adult Immunization (Senate Discussion Draft)
340B Drug Pricing Program
Program Implementation & Oversight
Implementation of Affordable Care Act
S. 1284: Department of Labor, HHS, Education and Related Agencies Appropriations Act for FY 2014
Funding for FDA
H.R. 2410/S. 1244: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014
H.J. Res. 59: The Bipartisan Budget Act of 2013
Independent Payment Advisory Board
Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
S. 1284: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014
H.J. Res. 59: The Bipartisan Budget Act of 2013
Biodefense Research, Development and Procurement Issues
Reimbursement for Innovative Products
Medicare Part B Physician-Administered Products
Medicare Part D Prescription Drug Program
Senate Finance Committee Discussion Draft
H.R. 1416: Cancer Patient Protection Act of 2013
Sequestration of PDUFA Fees
H.J. Res. 59: The Bipartisan Budget Act of 2013
H.R. 2410/S. 1244: Agriculture, Rural Development, FDA and Related Agencies Appropriations Act for FY 2014
HR 2725: Food and Drug Administration Safety Over Sequestration Act of 2013
Implementation of S. 365: Budget Control Act
S. 1413: FDA User Fee Protection Act
Transatlantic Trade and Investment Partnership
Regulatory Harmonization
Intellectual Property Issues
Drug Evaluation and Review
Special Medical Use/Limited Population Drug
H.R. 3742: Antibiotic Development to Advance Patient Treatment Act of 2013
Implementation of FDA Safety and Innovation Act
Orphan Drug Act Tax Credit
Drug Manufacturing, Quality & Distribution
Supply Chain Integrity
Pharmacy Compounding & Oversight
Drug Shortages
H.R. 3204: The Drug Quality & Security Act
Clinical Trial Data Sharing and Disclosure
EU Policies
TransPacific Partnership
Data and Intellectual Property Protection for Pharmaceuticals
Regulatory Transparency
Coordination of Federal Biotechnology Research
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. Trade Representative (USTR), Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Federal Trade Commission (FTC), Natl Security Council (NSC), Office of Management & Budget (OMB), U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Catharine |
Harris |
|
|
|
Andrew |
Emmett |
|
|
|
Charles |
Fritts |
|
|
|
Matthew |
Schumaker |
|
|
|
Jeanne |
Haggerty |
|
|
|
Sara |
Radcliffe |
|
|
|
Phyllis |
Arthur |
|
|
|
Anna |
Weinstein |
|
|
|
Derrick |
White |
|
|
|
Tom |
DiLenge |
|
|
|
Tracey |
LaTurner |
|
|
|
Laurel |
Todd |
|
|
|
Kelly |
Cappio |
|
|
|
Brent |
DelMonte |
|
|
|
Cartier |
Esham |
|
|
|
Charles |
Crain |
|
|
|
Cathleen |
Enright |
|
|
|
Matthew |
Carr |
|
|
|
Rina |
Singh |
|
|
|
Joseph |
Damond |
|
|
|
Dana |
O'Brien |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HOM
16. Specific lobbying issues
Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
S. 1284: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014
H.J. Res. 59: The Bipartisan Budget Act of 2013
Biodefense Research, Development and Procurement Issues
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Natl Security Council (NSC), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sara |
Radcliffe |
|
|
|
Phyllis |
Arthur |
|
|
|
Tracey |
LaTurner |
|
|
|
Kelly |
Cappio |
|
|
|
Brent |
DelMonte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
Funding for National Institutes of Health
S. 1284: Departments of Labor, HHS, Education, and related Agencies Appropriations Act for FY 2014
Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
S. 1284: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014
H.J. Res. 59: The Bipartisan Budget Act of 2013
Biodefense Research, Development and Procurement Issues
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Natl Security Council (NSC), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sara |
Radcliffe |
|
|
|
Jeanne |
Haggerty |
|
|
|
Kelly |
Cappio |
|
|
|
Phyllis |
Arthur |
|
|
|
Tracey |
LaTurner |
|
|
|
Brent |
DelMonte |
|
|
|
. |
. |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Independent Payment Advisory Board
Reimbursement for Innovative Products
Medicare Part B Physician-Administered Products
Medicare Part D Prescription Drug Program
Senate Finance Committee Discussion Draft
H.R. 1416: Cancer Patient Protection Act of 2013
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE,
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Brent |
DelMonte |
|
|
|
Laurel |
Todd |
|
|
|
Matthew |
Schumaker |
|
|
|
Jeanne |
Haggerty |
|
|
|
Catharine |
Harris |
|
|
|
Anna |
Weinstein |
|
|
|
Derrick |
White |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SMB
16. Specific lobbying issues
Sarbanes Oxley Section 404 (b)
Mandatory Audit Firm Rotation
H.R. 1564/S. 1526: The Audit Integrity and Job Protection Act
Capital Formation Investment Incentives
Reform of Passive Loss Rules
Reform of Net Operating Loss Rules
Reform of Capital Gains Rules
S. 1658: The Start-up Jobs and Innovation Act
Reform of SEC Regulation D
Implementation of Jumpstart Our Business Start-ups (JOBS) Act
Expansion of Exemption under SEC Regulation A
H.R. 701: To amend a provision of the Securities Act of 1933 directing the Securities and Exchange Commission
to add a particular class of securities to those exempted under such Act to provide a deadline for such action
Legislative Amendments to SEC Rule 12b-2 Filing Status Definitions
H.R. 2629: The Fostering Innovation Act
XBRL Exemption for Small Public Companies
Small Company Disclosure Simplification Act (Reps. Hurt and Sewell Discussion Draft)
Stock Exchange Tick Size
H.R. 1952: The Spread Pricing Liquidity Act
H.R. 3488: The Small Cap Liquidity Reform Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Treasury - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Charles |
Crain |
|
|
|
Charles |
Fritts |
|
|
|
Shelly |
Mui-Lipnik |
|
|
|
Brent |
DelMonte |
|
|
|
Cartier |
Esham |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Biofuels
Production Tax Credit Extension
Accelerated Depreciation Extension
H.R. 3758: Second Generation Biofuel Extension Act of 2013
Renewable Chemicals/Bio-based Products
Investment Tax Credit for Renewable Chemicals and Bio-based Products
New Production Tax Credit for Renewable Chemicals
Expansion of Master Limited Partnerships to Renewable Chemicals
H.R. 1696/S. 795: Master Limited Partnerships Parity Act
S. 1267/H.R. 3084: Renewable Chemical Production Tax Credit Act
Research & Development Tax Credit Reforms
Extension
Permanency
H.R.119: To amend the Internal Revenue Code to make permanent the credit for increasing research activities
H.R.3757: The Igniting American Research Act
The Innovative Research and Competitiveness Act (Senator Carper Discussion Draft),
The Start-up Innovation Credit Act (Senator Coons Discussion Draft)
Capital Formation Investment Incentives
Reform of Passive Loss Rules
Reform of Net Operating Loss Rules
Reform of Capital Gains Rules
S. 1658: The Start-up Jobs and Innovation Act
Tax Reform
Orphan Drug Act Tax Credit
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Treasury - Dept of,
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Carr |
|
|
|
Erick |
Lutt |
|
|
|
Anna |
Weinstein |
|
|
|
Tom |
DiLenge |
|
|
|
Rina |
Singh |
|
|
|
Charles |
Fritts |
|
|
|
Charles |
Crain |
|
|
|
Dana |
O'Brien |
|
|
|
Derrick |
White |
|
|
|
Shelly |
Mui-Lipnik |
|
|
|
Brent |
Del Monte |
|
|
|
Matthew |
Schumaker |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRD
16. Specific lobbying issues
Livestock Cloning/Product Labeling
Discussions with EU on Animal Cloning
Intellectual Property International Enforcement
Foreign Agricultural Biotechnology Laws and Regulations
China Biotechnology Regulations
Asynchrony of International Approvals
Genetic Resource Patent Disclosure Requirement
World Intellectual Property Organization
TransPacific Partnership
Regulatory Transparency
Data and Intellectual Property Protections for Pharmaceuticals
Sanitary and Phytosanitary Issues
Transatlantic Trade and Investment Partnership
Regulatory Harmonization
Ag-Biotech Issues
Intellectual Property Issues
Biosimilars
Colombia Biologics Regulations
Naming
Trade Promotion Authority
Clinical Trial Data Sharing and Disclosure
EU Policies
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. Trade Representative (USTR), Agriculture - Dept of (USDA), Health & Human Services - Dept of (HHS), Patent & Trademark Office (PTO), Federal Trade Commission (FTC), Natl Security Council (NSC), U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tom |
DiLenge |
|
|
|
David |
Edwards |
|
|
|
Brent |
DelMonte |
|
|
|
Joseph |
Damond |
|
|
|
Jeanne |
Haggerty |
|
|
|
Charles |
Fritts |
|
|
|
Matthew |
O'Mara |
|
|
|
Cathleen |
Enright |
|
|
|
Hans |
Sauer |
|
|
|
Dana |
O'Brien |
|
|
|
Derrick |
White |
|
|
|
Matthew |
Schumaker |
|
|
|
Sara |
Radcliffe |
|
|
|
Andrew |
Emmett |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address | |
||||||
| City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
| City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
5 |
|
||||||
| 2 |
|
6 |
|
||||||
| 3 |
|
7 |
|
||||||
| 4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address: BIO maintains a list of all of its members on its website at http://bio.org/membership/index.asp
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 3 | 5 |
| 2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 5 | 9 |
| 2 | 6 | 10 |
| 3 | 7 | 11 |
| 4 | 8 | 12 |